Korro Bio, Inc.KRRONASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor KRRO?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor KRRO

Key Statistics

About

frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

frequencytx.com →

Alerts

Key Statistics

About

News

Take-Two added to Wedbush's Best Ideas List on strong franchise moat, GTA VI potential

PayPal to Report Q4 Earnings: What Should Investors Do?

Imperial Oil Q4 Earnings Surpass Estimates, Revenues Miss

YUM to Post Q4 Earnings: What's in the Cards for the Stock?

Essity completes the acquisition of Edgewell's feminine care business

Telia, Lyse to combine Norwegian mobile radio networks to save costs

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Ramaco Resources, Inc. (METC)

CRA (CRAI) Moves 5.9% Higher: Will This Strength Last?

Are You Looking for a High-Growth Dividend Stock?

Morgan Stanley (MS) Could Be a Great Choice

First Mid Bancshares (FMBH) Could Be a Great Choice

Home BancShares (HOMB) Could Be a Great Choice

Are You Looking for a High-Growth Dividend Stock?

Why Cullen/Frost Bankers (CFR) is a Top Dividend Stock for Your Portfolio

Why Tompkins Financial (TMP) is a Great Dividend Stock Right Now

3 Stocks Trump Could Back Next as USA Rare Earths Revives the Federal Catalyst Trade

ManpowerGroup Stock Rises 9.1% Since Q4 Earnings and Revenue Beat

DAKT vs. GRMN: Which Stock Is the Better Value Option?

TTDKY vs. OSIS: Which Stock Is the Better Value Option?

NEXA vs. TECK: Which Stock Is the Better Value Option?

Explore More

Take-Two added to Wedbush's Best Ideas List on strong franchise moat, GTA VI potential

PayPal to Report Q4 Earnings: What Should Investors Do?

Imperial Oil Q4 Earnings Surpass Estimates, Revenues Miss

YUM to Post Q4 Earnings: What's in the Cards for the Stock?

Essity completes the acquisition of Edgewell's feminine care business

Telia, Lyse to combine Norwegian mobile radio networks to save costs

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Ramaco Resources, Inc. (METC)

CRA (CRAI) Moves 5.9% Higher: Will This Strength Last?

Are You Looking for a High-Growth Dividend Stock?

Morgan Stanley (MS) Could Be a Great Choice

First Mid Bancshares (FMBH) Could Be a Great Choice

Home BancShares (HOMB) Could Be a Great Choice

Are You Looking for a High-Growth Dividend Stock?

Why Cullen/Frost Bankers (CFR) is a Top Dividend Stock for Your Portfolio

Why Tompkins Financial (TMP) is a Great Dividend Stock Right Now

3 Stocks Trump Could Back Next as USA Rare Earths Revives the Federal Catalyst Trade

ManpowerGroup Stock Rises 9.1% Since Q4 Earnings and Revenue Beat

DAKT vs. GRMN: Which Stock Is the Better Value Option?

TTDKY vs. OSIS: Which Stock Is the Better Value Option?

NEXA vs. TECK: Which Stock Is the Better Value Option?

Key Statistics